The Business Research Company’s 2026 market reports feature advanced enhancements such as market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights, delivering more actionable and strategically valuable research.
What Is The Expected Market Value Outlook For The Dukoral Market Through 2030?
Historical growth was driven by cholera outbreaks in endemic regions, increasing international travel, official government vaccination advisories, the long-standing prevalence of waterborne diseases, and the expansion of travel health clinics.
Anticipated growth during the forecast period is propelled by factors such as a rise in global travel, the spread of cholera influenced by climate change, increased expenditure on preventive healthcare, developments in oral vaccine formulations, and a heightened emphasis on traveler health safety. Key trends anticipated in this period encompass the expanded adoption of oral vaccines, an increase in travel health immunization, a heightened concentration on preventing enteric diseases, a growing preference for non-injectable vaccines, and increased understanding of cholera and ETEC risks.
Download A Free Sample Report For Comprehensive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=20040&type=smp
What Core Drivers Are Transforming The Dukoral Market?
The increasing occurrence of cholera cases is anticipated to propel the expansion of the dukoral market. Cholera, an acute diarrheal illness resulting from consuming food or water tainted with Vibrio cholerae, can lead to critical dehydration and, in severe instances, death. The surge in cholera is exacerbated by inadequate sanitation, impure water, and climate change, creating favorable conditions for its spread. Dukoral, an oral cholera vaccine, aids in reducing cholera infections by building immunity against the Vibrio cholerae bacteria and its toxin, thereby lowering the chances of contracting the disease. For example, the World Health Organization (WHO), a Switzerland-based intergovernmental body, reported in September 2024 that cholera cases rose by 13% in 2023, alongside a notable 71% increase in deaths compared to 2022, amounting to over 4,000 fatalities from a disease that is both preventable and treatable. Consequently, the growing incidence of cholera cases is expected to stimulate the growth of the dukoral market.
Which Segment-Based Categories Are Covered In The Dukoral Market?
The dukoral market covered in this report is segmented –
1) By Indication: Cholera, Traveler’s Diarrhea
2) By Distribution Channel: Pharmacies, Travel Clinics, Healthcare Providers
3) By End Use: Hospitals, Clinics, Ambulatory Care, Home Care
Which Trends Are Contributing To Changes In The Dukoral Market?
Leading companies in the dukoral market are prioritizing innovation in vaccine formulations, particularly low-cost oral cholera vaccines, to boost efficacy and simplify administration. These affordable oral cholera vaccines are designed to prevent cholera, offering easier administration and accessibility, especially in resource-limited and outbreak-prone regions. As an illustration, in April 2023, the International Vaccine Institute (IVI), a South Korea-based non-profit international organization, joined forces with the University of Gothenburg, a Sweden-based institution, to create DuoChol, an economical oral cholera vaccine (OCV). This collaboration seeks to accelerate the development of DuoChol, which incorporates a dry formulation of inactivated bacterial whole cells and cholera toxin B subunit in a capsule. While similar in composition to DUKORAL, it boasts improved thermostability, greater stability at higher temperatures, and reduced weight and volume. The Phase I clinical trial is scheduled to be conducted in Sweden, backed by funding from the Wellcome Trust and the Swedish government.
Which Organizations Are Operating Within The Dukoral Market?
Major companies operating in the dukoral market are Valneva SE
Access The Complete Dukoral Market Report:
https://www.thebusinessresearchcompany.com/report/dukoral-global-market-report
Which Region Has The Strongest Presence In The Dukoral Market?
Asia-Pacific was the largest region in the dukoral market in 2025. The regions covered in the dukoral market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model